FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021474455> ?p ?o ?g. }

• W2021474455 endingPage "122" @default.
• W2021474455 startingPage "119" @default.
• W2021474455 abstract "Vaccination against Japanese Encephalitis (JE) has been carried out extensively in many Asian countries for the past 20 years. The vaccine was generally considered to be effective and of low reactogenity. However, since 1989 an unusual number of systemic reactions characterized mainly by generalized urticaria and/or angioedema following JE vaccination were reported from Australia, Canada and Denmark. 860 travellers were recruited during a period of 16 months for a prospective study with the aim to investigate the type and incidence of side effects following JE vaccination (JEV) in German travellers. 826 received a primary immunization (2 injections at days 0 and 7–14) and 34 received a single booster injection. A detailed standardized questionnaire was distributed to all vaccines after the first injection. A total of 509 questionnaires could be evaluated, which represents a return rate of 59.2%. 46% of the vaccinees reported about no adverse events at all. 54% reported about one or more adverse effects. Local reactions at the injection site were observed by 209 vaccinees, while 65 reported about systemic side effects like headache, fever, dizziness and generalized rash. There was no significant difference following first or second injection of the primary immunization or the booster injection, respectively, regarding incidence, severity or type of side effects. 2.2% of the vaccinees reporting reactions sought medical advice and 1.8% were judged unfit for work for an average of 2.2 days. The amount of systemic reactions might indicate a potential hazard of serious anaphylactic reactions. Unlike hepatitis A, Japanese encephalitis is an extremely rare disease in travellers. Therefore, the risk of acquiring the disease when travelling to affected areas without prior immunization should be considered against the risk of developing serious side effects after vaccination. We conclude that JEV should remain restricted to travellers with an increased risk of acquiring JE." @default.
• W2021474455 created "2016-06-24" @default.
• W2021474455 creator A5003002644 @default.
• W2021474455 creator A5023435835 @default.
• W2021474455 creator A5040106253 @default.
• W2021474455 creator A5061430871 @default.
• W2021474455 creator A5066402778 @default.
• W2021474455 creator A5078353739 @default.
• W2021474455 date "1996-03-01" @default.
• W2021474455 modified "2023-10-11" @default.
• W2021474455 title "Adverse reactions to Japanese encephalitis vaccine in travellers" @default.
• W2021474455 cites W1964079321 @default.
• W2021474455 cites W1966562339 @default.
• W2021474455 cites W1969671689 @default.
• W2021474455 cites W1982928319 @default.
• W2021474455 cites W2001731477 @default.
• W2021474455 cites W2008639080 @default.
• W2021474455 cites W2028015971 @default.
• W2021474455 cites W2045151225 @default.
• W2021474455 cites W2057898541 @default.
• W2021474455 cites W2097609886 @default.
• W2021474455 cites W2135004444 @default.
• W2021474455 cites W2317968120 @default.
• W2021474455 cites W2401837732 @default.
• W2021474455 doi "https://doi.org/10.1016/s0163-4453(96)91281-5" @default.
• W2021474455 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8708368" @default.
• W2021474455 hasPublicationYear "1996" @default.
• W2021474455 type Work @default.
• W2021474455 sameAs 2021474455 @default.
• W2021474455 citedByCount "56" @default.
• W2021474455 countsByYear W20214744552012 @default.
• W2021474455 countsByYear W20214744552013 @default.
• W2021474455 countsByYear W20214744552014 @default.
• W2021474455 countsByYear W20214744552015 @default.
• W2021474455 countsByYear W20214744552017 @default.
• W2021474455 countsByYear W20214744552018 @default.
• W2021474455 countsByYear W20214744552019 @default.
• W2021474455 countsByYear W20214744552020 @default.
• W2021474455 crossrefType "journal-article" @default.
• W2021474455 hasAuthorship W2021474455A5003002644 @default.
• W2021474455 hasAuthorship W2021474455A5023435835 @default.
• W2021474455 hasAuthorship W2021474455A5040106253 @default.
• W2021474455 hasAuthorship W2021474455A5061430871 @default.
• W2021474455 hasAuthorship W2021474455A5066402778 @default.
• W2021474455 hasAuthorship W2021474455A5078353739 @default.
• W2021474455 hasConcept C120665830 @default.
• W2021474455 hasConcept C121332964 @default.
• W2021474455 hasConcept C12590561 @default.
• W2021474455 hasConcept C126322002 @default.
• W2021474455 hasConcept C141071460 @default.
• W2021474455 hasConcept C159654299 @default.
• W2021474455 hasConcept C187212893 @default.
• W2021474455 hasConcept C197934379 @default.
• W2021474455 hasConcept C203014093 @default.
• W2021474455 hasConcept C22070199 @default.
• W2021474455 hasConcept C2522874641 @default.
• W2021474455 hasConcept C2777995640 @default.
• W2021474455 hasConcept C2778540732 @default.
• W2021474455 hasConcept C2778570526 @default.
• W2021474455 hasConcept C2779141303 @default.
• W2021474455 hasConcept C2780801004 @default.
• W2021474455 hasConcept C3018125106 @default.
• W2021474455 hasConcept C61511704 @default.
• W2021474455 hasConcept C71924100 @default.
• W2021474455 hasConcept C83455156 @default.
• W2021474455 hasConceptScore W2021474455C120665830 @default.
• W2021474455 hasConceptScore W2021474455C121332964 @default.
• W2021474455 hasConceptScore W2021474455C12590561 @default.
• W2021474455 hasConceptScore W2021474455C126322002 @default.
• W2021474455 hasConceptScore W2021474455C141071460 @default.
• W2021474455 hasConceptScore W2021474455C159654299 @default.
• W2021474455 hasConceptScore W2021474455C187212893 @default.
• W2021474455 hasConceptScore W2021474455C197934379 @default.
• W2021474455 hasConceptScore W2021474455C203014093 @default.
• W2021474455 hasConceptScore W2021474455C22070199 @default.
• W2021474455 hasConceptScore W2021474455C2522874641 @default.
• W2021474455 hasConceptScore W2021474455C2777995640 @default.
• W2021474455 hasConceptScore W2021474455C2778540732 @default.
• W2021474455 hasConceptScore W2021474455C2778570526 @default.
• W2021474455 hasConceptScore W2021474455C2779141303 @default.
• W2021474455 hasConceptScore W2021474455C2780801004 @default.
• W2021474455 hasConceptScore W2021474455C3018125106 @default.
• W2021474455 hasConceptScore W2021474455C61511704 @default.
• W2021474455 hasConceptScore W2021474455C71924100 @default.
• W2021474455 hasConceptScore W2021474455C83455156 @default.
• W2021474455 hasIssue "2" @default.
• W2021474455 hasLocation W20214744551 @default.
• W2021474455 hasLocation W20214744552 @default.
• W2021474455 hasOpenAccess W2021474455 @default.
• W2021474455 hasPrimaryLocation W20214744551 @default.
• W2021474455 hasRelatedWork W1970008980 @default.
• W2021474455 hasRelatedWork W2031554814 @default.
• W2021474455 hasRelatedWork W2037935456 @default.
• W2021474455 hasRelatedWork W2074980599 @default.
• W2021474455 hasRelatedWork W2123306763 @default.
• W2021474455 hasRelatedWork W2157506237 @default.
• W2021474455 hasRelatedWork W2358580141 @default.
• W2021474455 hasRelatedWork W2384238516 @default.

• next